Catheter Precision Inc (VTAK)
0.5472
0.00 (0.00%)
USD |
NYAM |
Apr 26, 16:00
0.5503
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Cash from Investing (Quarterly): -0.018M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.018M |
September 30, 2023 | -0.001M |
June 30, 2023 | -0.02M |
March 31, 2023 | -0.022M |
December 31, 2022 | 0.021M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | -0.001M |
September 30, 2021 | 3.345M |
June 30, 2021 | 0.169M |
March 31, 2021 | 0.289M |
December 31, 2020 | 0.005M |
September 30, 2020 | -0.023M |
Date | Value |
---|---|
June 30, 2020 | 4.979M |
March 31, 2020 | 10.97M |
December 31, 2019 | 9.952M |
September 30, 2019 | 10.67M |
June 30, 2019 | -36.49M |
March 31, 2019 | -0.165M |
December 31, 2018 | -0.158M |
September 30, 2018 | -0.173M |
June 30, 2018 | -0.131M |
March 31, 2018 | -0.12M |
December 31, 2017 | -0.272M |
September 30, 2017 | -0.034M |
June 30, 2017 | -0.01M |
March 31, 2017 | -0.231M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-36.49M
Minimum
Jun 2019
10.97M
Maximum
Mar 2020
0.2015M
Average
--
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
Perspective Therapeutics Inc | -0.089M |
Retractable Technologies Inc | -0.3478M |
InfuSystems Holdings Inc | -1.044M |
Xtant Medical Holdings Inc | -2.313M |
Asensus Surgical Inc | 7.427M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.889M |
Cash from Financing (Quarterly) | -0.107M |
Free Cash Flow | -20.70M |
Free Cash Flow Per Share (Quarterly) | -0.2709 |
Free Cash Flow to Equity (Quarterly) | -2.091M |
Free Cash Flow to Firm (Quarterly) | -1.907M |
Free Cash Flow Yield | -689.6% |